Ceftriaxone-Induced Immune Hemolytic Anemia

Curēus
Anil SinghSubhankar Samal

Abstract

Ceftriaxone is a commonly used antibiotic in hospitals for the treatment of pneumonia, urinary tract infection, bacteremia, meningitis, skin, and soft tissue infection. It can be associated with common allergic reactions like skin rash, itching, and, rarely, angioedema. Ceftriaxone-induced immune hemolytic anemia (IHA) is a rare and potentially fatal complication if not identified and managed in time. We report a case of ceftriaxone-induced IHA in a young woman.

References

Jul 26, 2005·Seminars in Hematology·Patricia A Arndt, George Garratty
Dec 24, 2015·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Beate MayerAbdulgabar Salama
Aug 15, 2019·The New England Journal of Medicine·Robert A Brodsky

❮ Previous
Next ❯

Citations

Feb 24, 2021·Molecular Biology Reports·Maria Elisabetta OnoriAngelo Minucci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Related Papers

The New Zealand Medical Journal
R R BaileyH B Cook
Revista clínica española
M López-GómezJ Jiménez-Alonso
Annals of Internal Medicine
A J LopezJ Pickleman
© 2021 Meta ULC. All rights reserved